litlas
Log inCreate account

David C. Hooper

Active 1893–2025

Also published as
DAVID C. HOOPER
128
Papers
29,335
Citations
94
h-index
122
i10-index

Citations

Citations per year for David C. Hooper1973: 1 citations1981: 1 citations1982: 2 citations1983: 2 citations1984: 1 citations1985: 5 citations1986: 13 citations1987: 25 citations1988: 35 citations1989: 54 citations1990: 35 citations1991: 62 citations1992: 30 citations1993: 59 citations1994: 64 citations1995: 55 citations1996: 69 citations1997: 63 citations1998: 76 citations1999: 75 citations2000: 90 citations2001: 85 citations2002: 104 citations2003: 126 citations2004: 107 citations2005: 177 citations2006: 211 citations2007: 139 citations2008: 288 citations2009: 179 citations2010: 192 citations2011: 199 citations2012: 222 citations2013: 194 citations2014: 220 citations2015: 187 citations2016: 195 citations2017: 198 citations2018: 180 citations2019: 720 citations2020: 797 citations2021: 824 citations2022: 590 citations2023: 434 citations2024: 670 citations2025: 323 citations2026: 11 citations1974–1980: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,205 citing papers, 24.7% of this breakdownChina: 700 citing papers, 7.9% of this breakdownUnited Kingdom: 564 citing papers, 6.3% of this breakdownFrance: 369 citing papers, 4.1% of this breakdownGermany: 334 citing papers, 3.8% of this breakdownIndia: 311 citing papers, 3.5% of this breakdownSpain: 306 citing papers, 3.4% of this breakdownItaly: 306 citing papers, 3.4% of this breakdownCanada: 304 citing papers, 3.4% of this breakdownAustralia: 269 citing papers, 3% of this breakdownJapan: 180 citing papers, 2% of this breakdownSwitzerland: 162 citing papers, 1.8% of this breakdown
0%24.7%Other 32.7%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology46.9%
  • Medicine30.8%
  • Immunology and Microbiology6.4%
  • Environmental Science4.5%
  • Agricultural and Biological Sciences3.8%
  • Chemistry1.5%
  • Other6.1%

Topics

  • Antibiotic Resistance in Bacteria15.8%
  • Antibiotics Pharmacokinetics and Efficacy6.1%
  • Antimicrobial Resistance in Staphylococcus4.2%
  • Pharmaceutical and Antibiotic Environmental Impacts3.8%
  • Antibiotic Use and Resistance3.5%
  • Bacterial Identification and Susceptibility Testing3.2%
  • Other63.4%

Coauthors

All papers

Open in search
  1. Raman Techniques: Fundamentals and Frontiers

    Authors: Robin R. Jones, David C. Hooper, Liwu Zhang, D. Wolverson, Ventsislav K. Valev - Nanoscale Research Letters 2019 cited by 777

  2. Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents

    Authors: Sameer S. Kadri, Jennifer Adjemian, Yi Ling Lai, Alicen B. Spaulding, Emily Ricotta, D. Rebecca Prevots, Tara N. Palmore, Chanu Rhee, Michael Klompas, John P. Dekker, John H. Powers, Anthony F. Suffredini, David C. Hooper, Scott K. Fridkin, Robert L. Danner - Clinical Infectious Diseases 2018 cited by 567

  3. Topoisomerase Inhibitors: Fluoroquinolone Mechanisms of Action and Resistance

    Authors: David C. Hooper, George A. Jacoby - Cold Spring Harbor Perspectives in Medicine 2016 cited by 533

  4. Mechanisms of drug resistance: quinolone resistance

    Authors: David C. Hooper, George A. Jacoby - Annals of the New York Academy of Sciences 2015 cited by 683

  5. Metallo-β-Lactamases: Structure, Function, Epidemiology, Treatment Options, and the Development Pipeline

    Authors: Sara E. Boyd, David M. Livermore, David C. Hooper, William Hope - Antimicrobial Agents and Chemotherapy 2020 cited by 291

  6. Hospital-Acquired Infections Due to Gram-Negative Bacteria

    Authors: Anton Y. Peleg, David C. Hooper - New England Journal of Medicine 2010 cited by 1,510

  7. A decision algorithm to promote outpatient antimicrobial stewardship for uncomplicated urinary tract infection

    Authors: Sanjat Kanjilal, Michael Oberst, Sooraj Boominathan, Helen Zhou, David C. Hooper, David Sontag - Science Translational Medicine 2020 cited by 92

  8. Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals

    Authors: Sameer S. Kadri, Yi Ling Lai, Sarah Warner, Jeffrey R. Strich, Ahmed Babiker, Emily Ricotta, Cumhur Y. Demirkale, John P. Dekker, Tara N. Palmore, Chanu Rhee, Michael Klompas, David C. Hooper, John H. Powers, Arjun Srinivasan, Robert L. Danner, Jennifer Adjemian - The Lancet Infectious Diseases 2020 cited by 270

  9. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase

    Authors: Ari Robicsek, Jacob Strahilevitz, George A. Jacoby, Mark J. Macielag, Darren Abbanat, Chi Hye Park, Karen Bush, David C. Hooper - Nature Medicine 2005 cited by 1,023

  10. Plasmid-Mediated Quinolone Resistance: a Multifaceted Threat

    Authors: Jacob Strahilevitz, George A. Jacoby, David C. Hooper, Ari Robicsek - Clinical Microbiology Reviews 2009 cited by 924

  11. Plasmid-Mediated Quinolone Resistance

    Authors: George A. Jacoby, Jacob Strahilevitz, David C. Hooper - Microbiology Spectrum 2014 cited by 463

  12. Antimicrobial blue light inactivation of pathogenic microbes: State of the art

    Authors: Yucheng Wang, Ying Wang, Yuguang Wang, Clinton K. Murray, Michael R. Hamblin, David C. Hooper, Tianhong Dai - Drug Resistance Updates 2017 cited by 292

  13. Mechanisms of Action of Antimicrobials: Focus on Fluoroquinolones

    Authors: David C. Hooper - Clinical Infectious Diseases 2001 cited by 507

  14. Emerging Mechanisms of Fluoroquinolone Resistance

    Authors: David C. Hooper - Emerging infectious diseases 2001 cited by 607

  15. The worldwide emergence of plasmid-mediated quinolone resistance

    Authors: Ari Robicsek, George A. Jacoby, David C. Hooper - The Lancet Infectious Diseases 2006 cited by 972

  16. Enterobacter Bacteremia: Clinical Features and Emergence of Antibiotic Resistance during Therapy

    Authors: Joseph W. Chow, Michael J. Fine, David M. Shlaes, John P. Quinn, David C. Hooper, Michaekl P. Johnson, Reuben Ramphal, Marilyn M. Wagener, D Miyashiro, Victor L. Yu - Annals of Internal Medicine 1991 cited by 895

  17. Genes Contributing to Staphylococcus aureus Fitness in Abscess- and Infection-Related Ecologies

    Authors: Michael D. Valentino, Lucy Foulston, Ama Sadaka, Veronica N. Kos, Régis Villet, John P. Santa Maria, David W. Lazinski, Andrew Camilli, Suzanne Walker, David C. Hooper, Michael S. Gilmore - mBio 2014 cited by 156

  18. Mechanisms of Action and Resistance of Older and Newer Fluoroquinolones

    Authors: David C. Hooper - Clinical Infectious Diseases 2000 cited by 399

  19. Impact of Intravenous Immunoglobulin on Survival in Necrotizing Fasciitis With Vasopressor-Dependent Shock: A Propensity Score–Matched Analysis From 130 US Hospitals

    Authors: Sameer S. Kadri, Bruce Swihart, Stephanie Bonne, Samuel F. Hohmann, Laura Hennessy, Peter Louras, Heather L. Evans, Chanu Rhee, Anthony F. Suffredini, David C. Hooper, Dean Follmann, Eileen M. Bulger, Robert L. Danner - Clinical Infectious Diseases 2016 cited by 121

  20. Prevalence in the United States of aac(6 ′ ) - Ib - cr Encoding a Ciprofloxacin-Modifying Enzyme

    Authors: Chi Hye Park, Ari Robicsek, George A. Jacoby, Daniel F. Sahm, David C. Hooper - Antimicrobial Agents and Chemotherapy 2006 cited by 750

  21. MgrA Is a Multiple Regulator of Two New Efflux Pumps inStaphylococcus aureus

    Authors: Q. C. Truong-Bolduc, Paul M. Dunman, Jacob Strahilevitz, Steven J. Projan, David C. Hooper - Journal of Bacteriology 2005 cited by 294

  22. Multi-institute analysis of carbapenem resistance reveals remarkable diversity, unexplained mechanisms, and limited clonal outbreaks

    Authors: Gustavo Cerqueira, Ashlee M. Earl, Christoph M. Ernst, Yonatan H. Grad, John P. Dekker, Michael Feldgarden, Sinéad B. Chapman, João Luís Reis-Cunha, Terrance Shea, Sarah Young, Qiandong Zeng, Mary L. Delaney, Diane Kim, Ellena M. Peterson, Thomas O’Brien, Mary Jane Ferraro, David C. Hooper, Susan S. Huang, James E. Kirby, Andrew B. Onderdonk, Susan J. Birren, Deborah T. Hung, Lisa A. Cosimi, Jennifer R. Wortman, Cheryl I. Murphy, William P. Hanage - National Academy of Sciences, Proceedings of the National Academy of Sciences 2017 cited by 170

  23. New Plasmid-Mediated Quinolone Resistance Gene, qnrC , Found in a Clinical Isolate of Proteus mirabilis

    Authors: Minghua Wang, Qinglan Guo, Xiaogang Xu, Xiaoying Wang, Xinyu Ye, Shi Wu, David C. Hooper, Minggui Wang - Antimicrobial Agents and Chemotherapy 2009 cited by 328

  24. oqxAB Encoding a Multidrug Efflux Pump in Human Clinical Isolates of Enterobacteriaceae

    Authors: Hong Bin Kim, Minghua Wang, Chi Hye Park, Eui-Chong Kim, George A. Jacoby, David C. Hooper - Antimicrobial Agents and Chemotherapy 2009 cited by 270